文献速递皮肤肿瘤

深度学习与临床列线图混合模型预测黑色素瘤前哨淋巴结转移

A deep learning-clinical nomogram hybrid for predicting sentinel lymph node metastasis in melanoma.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2025-09-03

本研究基于78例侵袭性皮肤黑色素瘤患者(43例SLNM阳性,35例阴性)的H&E全切片图像和临床数据,开发了CLAM-R50深度学习模型并与临床列线图整合,采用逻辑回归、支持向量机和梯度提升构建混合模型。梯度提升混合模型MISSLE在测试集上AUROC达0.950(95% bootstrap CI:0.933-1.00),高于CLAM-R50的0.875和临床列线图的0.826。注意力图显示淡染胞质和浆细胞样肿瘤细胞预测SLNM阳性,致密黑色素沉积和淋巴细胞样肿瘤细胞预测阴性。

要点

  • MISSLE混合模型在测试集AUROC达0.950,优于单独深度学习或临床模型。
  • CLAM-R50注意力图提示淡染胞质和浆细胞样肿瘤细胞与SLNM阳性相关。
  • 单中心、以日本人群为主的设计限制泛化性,需外部验证。

核心结论

  • MISSLE整合组织病理与临床数据预测SLNM,测试集AUROC为0.950(95% bootstrap CI:0.933-1.00),超过既往报道,可辅助临床决策。

研究设计与样本

  • 回顾性研究纳入2007-2022年山梨大学医院78例侵袭性皮肤黑色素瘤病例(43例SLNM阳性,35例阴性),分为训练集60例和测试集18例。
  • 使用H&E染色全切片图像开发CLAM模型,从四种变体中选出CLAM-R50(ResNet50trunc编码器,全组织区域训练)并与临床列线图整合。
  • 混合建模采用逻辑回归、支持向量机和梯度提升,梯度提升混合模型命名为MISSLE。

主要发现

  • 测试集上CLAM-R50的AUROC为0.875,临床列线图AUROC为0.826。
  • 梯度提升混合模型MISSLE的AUROC最高,为0.950(95% bootstrap CI:0.933-1.00)。
  • CLAM-R50注意力图识别淡染胞质和浆细胞样肿瘤细胞为SLNM阳性预测因子,致密黑色素沉积和淋巴细胞样肿瘤细胞为阴性预测因子。

临床怎么用

  • MISSLE可辅助侵袭性黑色素瘤患者前哨淋巴结活检的决策,代码和模型已公开供外部验证。

局限性

  • 单中心设计且以日本人群为主,限制泛化性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Melanoma is a life-threatening skin malignancy, with sentinel lymph node metastasis (SLNM) serving as a critical prognostic factor. While machine and deep learning models using histopathology have focused on melanoma diagnosis, limited efforts have aimed to predict SLNM. OBJECTIVES: This study aimed to develop a collaborative machine and deep learning model that integrates histopathological patches and clinical data to predict SLNM in patients with invasive melanoma, thereby aiding decision-making regarding sentinel lymph node biopsy. METHODS: A total of 78 invasive cutaneous melanoma cases (43 SLNM-positive and 35 SLNM-negative) from the University of Yamanashi Hospital (2007-2022) were divided into training (n = 60) and test (n = 18) datasets. A clustering-constrained attention multiple-instance learning (CLAM) model was developed using haematoxylin and eosin-stained whole-slide images. Among the four CLAM variants, the model using a ResNet50trunc encoder trained on whole-tissue regions (CLAM-R50) demonstrated the best performance and was further integrated with a clinical nomogram. Hybrid modelling was performed using logistic regression, a support vector machine and gradient boosting. RESULTS: CLAM-R50 achieved an area under the receiver operating characteristic curve (AUROC) of 0.875, while the clinical nomogram achieved an AUROC of 0.826 on the test set. The gradient boosting hybrid model, termed the Melanoma Indicative Scorer for Sentinel Lymph node Evaluation (MISSLE), demonstrated the highest AUROC of 0.950 (95% bootstrapped confidence interval (CI): 0.933-1.00) on the test set. CLAM-R50 attention maps identified pale cytoplasm and plasma cell-like tumour cells as predictors of positive SLNM, whereas dense melanin deposition and lymphocyte-like tumour cells predicted negative SLNM. CONCLUSIONS: MISSLE integrates histopathological and clinical data to predict SLNM with high AUROC, surpassing the previous reports and offering a tool for clinical decision-making. Limitations include the single-centre design and predominantly Japanese cohort, limiting generalizability. The code and models are publicly available for external validation.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Le MK, Kawai M, Kondo T, et al. A deep learning-clinical nomogram hybrid for predicting sentinel lymph node metastasis in melanoma. J Eur Acad Dermatol Venereol. 2025. PMID: 40900446. doi:10.1111/jdv.70000

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。